These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28762650)

  • 1. Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.
    Blagden S; Abdel Mouti M; Chettle J
    Wiley Interdiscip Rev RNA; 2018 Jan; 9(1):. PubMed ID: 28762650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.
    Boyerinas B; Park SM; Murmann AE; Gwin K; Montag AG; Zillhardt M; Hua YJ; Lengyel E; Peter ME
    Int J Cancer; 2012 Apr; 130(8):1787-97. PubMed ID: 21618519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational remodeling by RNA-binding proteins and noncoding RNAs.
    Ho JJD; Man JHS; Schatz JH; Marsden PA
    Wiley Interdiscip Rev RNA; 2021 Sep; 12(5):e1647. PubMed ID: 33694288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts.
    Zhao L; Wang W; Huang S; Yang Z; Xu L; Yang Q; Zhou X; Wang J; Shen Q; Wang C; Le X; Feng M; Zhou N; Lau WB; Lau B; Yao S; Yi T; Wang X; Zhao X; Wei Y; Zhou S
    Genome Biol; 2018 Mar; 19(1):35. PubMed ID: 29548303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circuitry of mRNA regulation.
    Kanitz A; Gerber AP
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(2):245-251. PubMed ID: 20836026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer.
    Wambecke A; Ahmad M; Lambert B; Joly F; Poulain L; Denoyelle C; Meryet-Figuiere M
    Gynecol Oncol; 2020 Mar; 156(3):726-733. PubMed ID: 31883617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.
    Xu Z; Li X; Li H; Nie C; Liu W; Li S; Liu Z; Wang W; Wang J
    Oncogene; 2020 Nov; 39(47):7051-7062. PubMed ID: 32989256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.
    Hopkins TG; Mura M; Al-Ashtal HA; Lahr RM; Abd-Latip N; Sweeney K; Lu H; Weir J; El-Bahrawy M; Steel JH; Ghaem-Maghami S; Aboagye EO; Berman AJ; Blagden SP
    Nucleic Acids Res; 2016 Feb; 44(3):1227-46. PubMed ID: 26717985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression.
    Fu L; Zhang D; Yi N; Cao Y; Wei Y; Wang W; Li L
    Hum Cell; 2022 Sep; 35(5):1560-1576. PubMed ID: 35907138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Paneth Cell Function by RNA-Binding Proteins and Noncoding RNAs.
    Chung HK; Xiao L; Jaladanki KC; Wang JY
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation and competition by RNA-binding proteins in cancer.
    Nag S; Goswami B; Das Mandal S; Ray PS
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):286-297. PubMed ID: 35248729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of protein translation and its implications for cancer.
    Song P; Yang F; Jin H; Wang X
    Signal Transduct Target Ther; 2021 Feb; 6(1):68. PubMed ID: 33597534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endonuclease Regnase-1/Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) in controlling immune responses and beyond.
    Takeuchi O
    Wiley Interdiscip Rev RNA; 2018 Jan; 9(1):. PubMed ID: 28929622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.
    Ehlén A; Brennan DJ; Nodin B; O'Connor DP; Eberhard J; Alvarado-Kristensson M; Jeffrey IB; Manjer J; Brändstedt J; Uhlén M; Pontén F; Jirström K
    J Transl Med; 2010 Aug; 8():78. PubMed ID: 20727170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coupled and uncoupled mechanisms by which trans-acting factors regulate mRNA stability and translation.
    Fukao A; Fujiwara T
    J Biochem; 2017 Apr; 161(4):309-314. PubMed ID: 28039391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of drug resistance in ovarian cancer.
    Norouzi-Barough L; Sarookhani MR; Sharifi M; Moghbelinejad S; Jangjoo S; Salehi R
    J Cell Physiol; 2018 Jun; 233(6):4546-4562. PubMed ID: 29152737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long (lncRNA) and Short (miRNA) of It: TGFβ-Mediated Control of RNA-Binding Proteins and Noncoding RNAs.
    Janakiraman H; House RP; Gangaraju VK; Diehl JA; Howe PH; Palanisamy V
    Mol Cancer Res; 2018 Apr; 16(4):567-579. PubMed ID: 29555893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptional control of airway inflammation.
    Ezegbunam W; Foronjy R
    Wiley Interdiscip Rev RNA; 2018 Jan; 9(1):. PubMed ID: 29071794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.